SE
Sheila Eshiwani

Publications (1)

Switching treatment-experienced, integrase inhibitor-naive, virally suppressed HIV-1 infected adults from ritonavir-boosted protease inhibitors to dolutegravir: design, methods, and baseline results of a randomized, open-label, non-inferiority trial
Article scientifique · 2022

Domaines principaux

Sciences de la santé1

Statistiques

Consultations0
Téléchargements0